COHIVE: Coronavirus (COVID-19) Outcomes in HIV Evaluation in Resource Limited Settings

CompletedOBSERVATIONAL
Enrollment

596

Participants

Timeline

Start Date

August 12, 2020

Primary Completion Date

December 31, 2021

Study Completion Date

December 31, 2021

Conditions
HIV-infection/AidsCoronavirus Infection
Trial Locations (15)

263

University of Zimbabwe Clinical Research Centre, Harare

2013

Perinatal HIV Research Unit (PHRU), Johannesburg

2041

Clinical HIV Research Unit (CHRU), Wits Health Consotium (Pty) Ltd, Johannesburg

2193

Ezintsha, Parktown

7925

Desmond Tutu HIV Foundation, Cape Town

9396

Institute of Human Virology, Nigeria (IHVN), Abuja

10330

HIV-NAT (The HIV Netherlands Australia Thailand Research Collaboration), Thai Red Cross AIDS Research Centre, Bangkok

600113

CART CRS, VHS Hospital, Chennai

C1221ADC

Hospital G de Agudos JM Ramos Mejia, Buenos Aires

21040-360

Laboratório de Pesquisa Clinica Em Hiv/Aids - Instituto Nacional de Infectologia - Fiocruz, Rio de Janeiro

Unknown

Central Hospital of Yaoundé, Yaoundé

Cité Verte Hospital, Yaoundé

Hôpital Militaire de Région N°1, Yaoundé

Univerity of Malaya Medical Centre, Kuala Lumpur

Infectious Diseases Institute, Kampala

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

University of Witwatersrand, South Africa

OTHER

collaborator

University of Liverpool

OTHER

collaborator

Université Montpellier

OTHER

collaborator

UNITAID

OTHER

collaborator

ViiV Healthcare

INDUSTRY

lead

Kirby Institute

OTHER_GOV